Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin.
about
Dermacase. Atrophic patchesLongitudinal in vivo tracking of adverse effects following topical steroid treatment.Chinese herbal medicine (Tuhuai extract) exhibits topical anti-proliferative and anti-inflammatory activity in murine disease modelsFluorescence spectroscopy as a tool to detect and evaluate glucocorticoid-induced skin atrophy.Calcipotriol counteracts betamethasone-induced decrease in extracellular matrix components related to skin atrophyEosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitisTopical hesperidin prevents glucocorticoid-induced abnormalities in epidermal barrier function in murine skin.Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases.Randomized, prospective assessment of moisturizer efficacy for the treatment of radiation dermatitis following radiotherapy after breast-conserving surgeryMechanisms of action of topical corticosteroids in psoriasisGlucocorticoid therapy-induced skin atrophy.Is pimecrolimus cream (1%) an appropriate therapeutic agent for the treatment of external ear atopic dermatitis?An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance.Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis.Kinetics of Clobetasol-17-Propionate in Psoriatic Lesional and Non-Lesional Skin Assessed by Dermal Open Flow Microperfusion with Time and Space ResolutionOccupational skin diseases: options for multidisciplinary networking in preventive medicine.Pilot randomised controlled trial of protective socks against usual care to reduce skin tears in high risk people "STOPCUTS": study protocol.Skin barrier in atopic dermatitis.Topical corticosteroid-induced skin atrophy: a comprehensive review.Therapeutic effect of Castellani's paint in patients with an itchy ear canal.Test systems for the determination of glucocorticoid receptor ligand induced skin atrophy.Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial.A comparative study of the effects of retinol and retinoic acid on histological, molecular, and clinical properties of human skin.Pilot parallel randomised controlled trial of protective socks against usual care to reduce skin tears in high risk people: 'STOPCUTS'.New treatment strategy and assessment questionnaire for external auditory canal pruritus: topical pimecrolimus therapy and Modified Itch Severity Scale.An open-label study of the safety and efficacy of limited application of fluticasone propionate ointment, 0.005%, in patients with atopic dermatitis of the face and intertriginous areas.Morphological changes in skin of different phototypes under the action of topical corticosteroid therapy and tacrolimus.Topical herbal extract (Huangdang mixture) exhibits both preventive and therapeutic effects in murine acute irritant contact dermatitis.The effect of a corticosteroid cream and a barrier-strengthening moisturizer in hand eczema. A double-blind, randomized, prospective, parallel group clinical trial.Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.Therapeutic benefits of natural ingredients for atopic dermatitis.[Lupoid perioral dermatitis as a special form of perioral dermatitis: review of pathogenesis and new therapeutic options].Potential treatment of atopic dermatitis: tolerability and safety of cream containing nanoparticles loaded with hydrocortisone and hydroxytyrosol in human subjects.First results from the multicentre study rehabilitation of occupational skin diseases--optimization and quality assurance of inpatient management (ROQ).Topical cosmetics and perioral dermatitis.Effects of a multilamellar emulsion on glucocorticoid-induced epidermal atrophy and barrier impairment.Sub-clinical assessment of atopic dermatitis severity using angiographic optical coherence tomography.Late cutaneous effects of a local potent steroid during adjuvant radiotherapy for breast cancer.Werner syndrome: quantitative assessment of skin agingTacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis
P2860
Q24681907-F5ADF768-3A53-45AA-983B-8347546CA219Q30756145-DAECF4B8-C260-43C3-8907-1C48C4F0A412Q33744890-5989CEDF-6B72-4FED-91FF-3432B6B84BABQ34128917-E5207109-3C56-4F3D-992B-8740F949570AQ34207525-8B1C3259-B933-44E3-A7C6-C42E1CBFCAE8Q34882570-AABCCFCB-F5FD-4551-9860-10EF238947D6Q35843367-C86E98F1-0EDC-4160-8D1C-FB7BD7490AD3Q35988645-34AF951B-47BC-4F2F-BFBA-493F55A96584Q36299822-950767CD-B1FC-49C6-B773-2D445CFF74C7Q36429698-E9F1C7C3-D173-4095-852E-E0890568A15FQ36475498-7EABB90E-5889-4B0E-B3DD-5C54B3883B86Q36577730-6421767B-1F7C-42D8-9E22-8C301003B501Q37049990-68337920-DCA3-4F36-9011-988D377506E7Q37070498-C550C984-BE6A-40F4-A2FD-43DB5CE04F51Q37139312-D7091DDE-51CF-4C54-812A-B841D03C90E2Q37244132-B32D8415-58DC-4816-81F4-E903D4FF5065Q37498345-470C4787-E813-4287-A627-8A95373340D4Q37762460-7C170BAC-ED97-442F-B372-4316073F33C4Q38415302-76247B3B-1B27-440A-B7A1-16B9496693A6Q39165462-772C650A-96BA-487D-B263-EE0C7EA07F7DQ39194377-0ABF26BB-61DC-4567-AC1D-8D1CB47022F9Q40289504-31432AB4-DB8D-4568-91F0-B253C2D88A6DQ40331324-1A944F41-2D09-4C36-BBF0-C2C2278D38C9Q42689770-E3285532-7324-419E-9D90-556E1E37DA4DQ43239478-1860BF24-7A78-4FC8-AF8D-02D045EF4EC3Q44230165-9E782CF9-6486-46A4-8758-47D27E0DA323Q45759999-E5BC00FF-2885-4A0E-B93B-602409E787CFQ46069466-A52DD44F-1CD9-4F73-A66C-0FC15801A57BQ46104666-56DB85C0-941E-4F7C-9ECE-78D81BD5981CQ46701419-B2986C35-DE13-421B-894B-03D4AFB539C6Q46710832-25F9C4B9-55F2-42FA-B42E-6814AC5B2DB1Q46747014-DA9AD498-CAFA-4F57-9991-8C2C63A0AF81Q47787858-2F4D5ECB-2B10-4384-8A18-D5630C0CDAC5Q48550060-C30E6F02-4D1E-4ECD-976A-93B18B084BCBQ51960291-A7B6777E-5CBF-44AF-A3EB-B9471C4E1D7AQ53601232-4BBFDA32-2921-4EEC-88E2-FFEF7B6D9750Q55083172-E0C93B2B-105A-49D0-810C-45C77A3E5C27Q55182805-A2D6B5A2-6ACC-4B3B-B867-85B1B4AD4D1FQ57171757-985558D6-EB39-487E-BD4C-799080BB8824Q57266992-E10FC6B8-E9C9-4497-92DC-2ABF865B3F21
P2860
Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Corticosteroid-induced atrophy ...... nvasive methods in human skin.
@ast
Corticosteroid-induced atrophy ...... nvasive methods in human skin.
@en
type
label
Corticosteroid-induced atrophy ...... nvasive methods in human skin.
@ast
Corticosteroid-induced atrophy ...... nvasive methods in human skin.
@en
prefLabel
Corticosteroid-induced atrophy ...... nvasive methods in human skin.
@ast
Corticosteroid-induced atrophy ...... nvasive methods in human skin.
@en
P2093
P1476
Corticosteroid-induced atrophy ...... nvasive methods in human skin.
@en
P2093
Kligman AM
Schreiner V
Stoudemayer T
P356
10.1034/J.1600-0846.2001.70203.X
P577
2001-05-01T00:00:00Z